From May 31, 2023 to February 26, 2024, the company has repurchased 56,975,656 shares, representing 4.37% for $53.34 million. With this, the company has completed the repurchase of 56,975,656 shares, representing 4.37% for $53.34 million under the buyback announced on May 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.846 USD | +0.24% | +0.48% | +0.71% |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
May. 02 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
1st Jan change | Capi. | |
---|---|---|
+0.71% | 1.03B | |
+7.56% | 13.23B | |
+16.59% | 9.88B | |
+3.51% | 5.77B | |
+8.08% | 5.31B | |
+23.89% | 4.78B | |
-6.40% | 4.62B | |
+19.79% | 4.47B | |
+1.53% | 4B | |
+3.58% | 3.98B |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- Tranche Update on BioPharma Credit PLC's Equity Buyback Plan announced on May 31, 2023.